Pharmaceutical Technology-04-02-2019

Pharmaceutical Technology

Channeling Customer Complaints into Quality

April 02, 2019

Ask the Expert

43

4

A robust customer complaint handling system is an integral part of a quality management system, says Susan Schniepp, executive vice-president of post-approval pharma and distinguished fellow, Regulatory Compliance Associates.

Continuous Manufacturing Gains Major Push from FDA

April 02, 2019

Regulatory Watch

43

4

FDA is moving to shift industry away from step-wise batch production.

Spray Drying: Supporting Patient-Centric Drug Development

April 02, 2019

Cover Story

43

4

Pharmaceutical Technology Europe spoke with Manuel Leal, business development director for Idifarma to learn more about spray drying and how it can support patient-centric drug development.

Designing for Patient and Public Health

April 02, 2019

From the Editor

43

4

Better drug design and patient education may promote improved personal and public health.

Successful Technology Transfer

April 02, 2019

Features

43

4

Pharmaceutical Technology spoke with Roger Croucher, senior manager, R&D projects, at Catalent Pharma Solutions; Daniel M. Bowles, senior director, chemical development, at Cambrex; and Kurt J Kiewel, director, new product development and analytical services, also at Cambrex about best practices for a successful technology transfer.

New MALS Detector

April 02, 2019

Product Spotlight

43

4

Tosoh Bioscience’s LenS3 Multi-Angle Light Scattering (MALS) detector offers a new approach for measuring molecular weight (MW) and radius of gyration (Rg) of synthetic polymers, polysaccharides, proteins, and biopolymers.

Pharmaceutical Technology North America, April 2019 (PDF)

April 02, 2019

Issue PDF

43

4

Click the title above to open the Pharmaceutical Technology April 2019 issue in an interactive PDF format.

Pulling Together to Advance Patient-Focused Drug Products

April 02, 2019

Cover Story

43

4

More work needed to advance drug design and development effectively.

Regulating Pharmaceuticals in the Environment

April 01, 2019

Regulatory Watch

43

4

The European Commission has published a strategy that will form the basis for the European Union’s policy on pharmaceuticals in the environment.

Doing the Brexit Hokey Cokey

April 01, 2019

From the Editor

43

4

Uncertainty remains around the UK’s departure from the EU, potentially causing irreparable damage to the bio/pharma sector.